Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biohaven Pharmaceutical Holding Co Ltd.

19.17
-3.4500-15.25%
Post-market: 20.100.9300+4.85%19:56 EDT
Volume:3.30M
Turnover:65.60M
Market Cap:1.96B
PE:-2.07
High:22.22
Open:22.00
Low:18.99
Close:22.62
Loading ...

Biohaven's spinal muscular atrophy drug fails to meet main goal in study

Reuters
·
25 Nov 2024

BRIEF-Biohaven Provides Update On Taldefgrobep Alfa Development Program

Reuters
·
25 Nov 2024

Biohaven Shares Fall 12.3% Premarket as Sma Treatment Did Not Show Statistically Significant Difference on Primary Outcome in Trial

THOMSON REUTERS
·
25 Nov 2024

Biohaven Provides Update on Taldefgrobep Alfa Development Program for Spinal Muscular Atrophy and Obesity

THOMSON REUTERS
·
25 Nov 2024

Biohaven Ltd - Taldefgrobep Well-Tolerated With No Treatment-Related Saes

THOMSON REUTERS
·
25 Nov 2024

Biohaven Provides Update on Taldefgrobep Alfa Development Program for Spinal Muscular Atrophy and Obesity

PR Newswire
·
25 Nov 2024

Here are 4 biotech stocks that could get a boost from Trump's new regulatory climate

Dow Jones
·
23 Nov 2024

Here are 4 biotech stocks that could get a boost from Trump's new regulatory climate

Dow Jones
·
20 Nov 2024

Biotech-stock investing has one tough test for success - and it's about to get easier

Dow Jones
·
18 Nov 2024

Biohaven Ltd. (BHVN) Receives a Buy from Morgan Stanley

TIPRANKS
·
15 Nov 2024

Biohaven Price Target Maintained With a $59.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Nov 2024

Biohaven Is Maintained at Outperform by RBC Capital

Dow Jones
·
13 Nov 2024

Bank of America Securities Remains a Buy on Biohaven Ltd. (BHVN)

TIPRANKS
·
13 Nov 2024

Piper Sandler Reaffirms Their Buy Rating on Biohaven Ltd. (BHVN)

TIPRANKS
·
13 Nov 2024

RBC Cuts Price Target on Biohaven to $66 From $68, Keeps Outperform, Speculative Risk

MT Newswires Live
·
13 Nov 2024

RBC Capital Keeps Their Buy Rating on Biohaven Ltd. (BHVN)

TIPRANKS
·
13 Nov 2024

Biohaven Non-GAAP EPS of -$1.74 misses by $0.24

seekingalpha
·
13 Nov 2024

U.S. RESEARCH ROUNDUP- AMN Healthcare Services, Chart Industries, Home Depot

Reuters
·
13 Nov 2024

Biohaven Ltd : TD Cowen Raises Target Price to $75 From $55

THOMSON REUTERS
·
13 Nov 2024

Biohaven Q3 Adj $(1.74) Misses $(1.72) Estimate

Benzinga
·
13 Nov 2024